• Info
  • Insider Ownership

Insider Trading & Ownership of Clarus Lifesciences III, L.P.

Location
Cambridge, MA
Summary
The estimated net worth of Clarus Lifesciences III, L.P. is at least $211,504,686 dollars as of 01 Apr 2022. Clarus Lifesciences III, L.P. is the 10%+ Owner of Praxis Precision Medicines, Inc. and owns shares of Praxis Precision Medicines, Inc. (PRAX) stock worth about $123.28M. Clarus Lifesciences III, L.P. is the 10%+ Owner of Imago BioSciences, Inc. and owns shares of Imago BioSciences, Inc. stock worth about $85.5M. Clarus Lifesciences III, L.P. is the 10%+ Owner of Tourmaline Bio, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $2.72M.
Signature
CLARUS LIFESCIENCES III, L.P., By: Clarus Ventures III GP, L.P., its general partner, By: Blackstone Clarus III, L.L.C., its general partner, By: /s/ Omar Rehman, Name: Omar Rehman, Title: Chief Compliance Officer and Secretary
All Insider Reports
All Insider Reports

Notify me when Clarus Lifesciences III, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Clarus Lifesciences III, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PRAX Praxis Precision Medicines, Inc. 10%+ Owner $123,282,606 12 May 2021
IMGO Imago BioSciences, Inc. 10%+ Owner $85,501,332 30 Mar 2022
TRML Tourmaline Bio, Inc. 10%+ Owner $2,720,748 11 May 2021

Insider Transactions Reported by Clarus Lifesciences III, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.